Rehues, P.;                     Girona, J.;                     Guardiola, M.;                     Plana, N.;                     Scicali, R.;                     Piro, S.;                     Muñiz-Grijalvo, O.;                     DÃaz-DÃaz, J.L.;                     Recasens, L.;                     Pinyol, M.;     
    et al.    PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. Int. J. Mol. Sci. 2023, 24, 2319.
    https://doi.org/10.3390/ijms24032319
    AMA Style
    
                                Rehues P,                                 Girona J,                                 Guardiola M,                                 Plana N,                                 Scicali R,                                 Piro S,                                 Muñiz-Grijalvo O,                                 DÃaz-DÃaz JL,                                 Recasens L,                                 Pinyol M,         
        et al.        PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International Journal of Molecular Sciences. 2023; 24(3):2319.
        https://doi.org/10.3390/ijms24032319
    
    Chicago/Turabian Style
    
                                Rehues, Pere,                                 Josefa Girona,                                 Montse Guardiola,                                 Núria Plana,                                 Roberto Scicali,                                 Salvatore Piro,                                 Ovidio Muñiz-Grijalvo,                                 José Luis DÃaz-DÃaz,                                 LluÃs Recasens,                                 Marta Pinyol,         
         and et al.        2023. "PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk" International Journal of Molecular Sciences 24, no. 3: 2319.
        https://doi.org/10.3390/ijms24032319
    
    APA Style
    
                                Rehues, P.,                                 Girona, J.,                                 Guardiola, M.,                                 Plana, N.,                                 Scicali, R.,                                 Piro, S.,                                 Muñiz-Grijalvo, O.,                                 DÃaz-DÃaz, J. L.,                                 Recasens, L.,                                 Pinyol, M.,                                 Rosales, R.,                                 Esteban, Y.,                                 Amigó, N.,                                 Masana, L.,                                 Ibarretxe, D.,                                 & Ribalta, J.        
        
        (2023). PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk. International Journal of Molecular Sciences, 24(3), 2319.
        https://doi.org/10.3390/ijms24032319